| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2021 | May 21, 2021 | Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 46.3 | -42,061 | -13.33% | ✗ | $36.2K |
| Jun 5, 2020 | Jun 8, 2020 | Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 42.5 | -31,548 | -21.46% | ✗ | $104.4K |
| May 22, 2020 | May 26, 2020 | Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 42.5 | -39,435 | -21.15% | ✗ | $196.8K |
| May 6, 2020 | May 8, 2020 | Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 46.3 | -7,792 | -4.01% | ✗ | $40.8K |
| Apr 30, 2020 | May 1, 2020 | Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 50.0 | -2,000 | -1.02% | ✓ | $9.4K |
| Feb 19, 2020 | Feb 21, 2020 | Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 52.5 | -1,000 | -0.51% | ✓ | $7K |
| Dec 2, 2019 | Dec 4, 2019 | Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 46.3 | -1,000 | -2.25% | ✓ | $7.4K |
| Nov 25, 2019 | Nov 26, 2019 | Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 46.3 | -5,187 | -10.43% | ✗ | $32.3K |
| Nov 20, 2019 | Nov 21, 2019 | Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 46.3 | -5,187 | -9.45% | ✗ | $29.8K |
| Aug 22, 2019 | Aug 26, 2019 | Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 47.5 | -864 | -1.55% | ✗ | $4.4K |
| Jun 10, 2019 | Jun 12, 2019 | Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 46.3 | -5,187 | -8.51% | ✗ | $33K |
| Apr 1, 2019 | Apr 3, 2019 | Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 47.5 | -1,022 | -1.65% | ✗ | $3.6K |
| Aug 16, 2018 | Aug 20, 2018 | Evofem Biosciences, Inc. | Chief Medical Officer | Buy | 90.0 | +3,000 | 33.39% | ✗ | $6.7K |
| Jul 2, 2018 | Jul 3, 2018 | Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 91.3 | +8,985 | 100.00% | ✗ | $11.7K |